Covis Pharma, the maker of Makena, is planning the withdrawal after a study failed to confirm the drug works Makena was the only drug approved by the FDA to reduce the risk of preterm birth in women with a history of early deliveries.
Covis Pharma Group said it will stop selling itsjust call it a supplement and nobody says diddly
How did it get approved in the first place?
Good, do aducanumab next.
Wtf are these things let out before we know this. Jesus f----- Christ
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: